Clinical study of combination therapy with high-dose moxibustion for herpes zoster/postherpetic neuralgia
- Conditions
- Herpes zoster, postherpetic neuralgia
- Registration Number
- ITMCTR2100005221
- Lead Sponsor
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Those who meet the diagnostic criteria of traditional Chinese and Western medicine for herpes zoster;
2. Aged 18-70 years, no gender limit;
3. Visual analog scale (VAS) score >= 4 points before treatment, and no relevant treatment within one week before enrollment;
4. Herpes occurs on the body and limbs;
5. Those who voluntarily participated in this study and signed the informed consent.
1. Pregnant patients;
2. Patients who are unable to express their own symptoms voluntarily, or have disorders of consciousness, coagulation disorders, and sensory disorders;
3. Allergic constitution or allergic to acupuncture;
4. Patients with serious primary diseases;
5. Progressive malignant tumor or other serious wasting disease, easy to be complicated by infection and bleeding;
6. Those with other diseases that cause pain;
7. Those who are participating in other clinical trials recently.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual analogue scale;Prevalence of postherpetic neuralgia;
- Secondary Outcome Measures
Name Time Method Self-rating anxiety scale;Health-related quality of life assessment;Pittsburgh sleep quality index;Shingles transient pain scale;Self-rating depression scale;